| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
233,220,000 |
| Market
Cap: |
76.96(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.21 - $0.61 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Computer Software |
| Level
III Sector: |
Application Software |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Asensus Surgical is a medical device company. Co. is focused on the market development for and commercialization of the Senhance® Surgical System, which digitizes laparoscopic minimally invasive surgery (MIS). The Senhance Surgical System is a multi-port laparoscopic platform designed to maintain laparoscopic MIS standards. The Senhance System is available in Europe, the U.S., Japan, Taiwan, Russia and select other countries. The Senhance System has a CE Mark in Europe for adult and pediatric laparoscopic abdominal and pelvic surgery, as well as limited thoracic surgeries excluding cardiac and vascular surgery.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
18,134 |
604,288 |
| Total Buy Value |
$0 |
$0 |
$5,078 |
$420,192 |
| Total People Bought |
0 |
0 |
1 |
2 |
| Total Buy Transactions |
0 |
0 |
1 |
3 |
| Total Shares Sold |
0 |
0 |
18,134 |
18,134 |
| Total Sell Value |
$0 |
$0 |
$5,078 |
$5,078 |
| Total People Sold |
0 |
0 |
1 |
1 |
| Total Sell Transactions |
0 |
0 |
1 |
1 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hsiao Jane Ph D |
Chairman of the Board |
– • • |
2010-06-15 |
4 |
B |
$1.00 |
$1,300,000 |
I/I |
1,300,000 |
1,360,000 |
2.25 |
- |
|
| Frost Gamma Investment Trust |
10% Owner |
– – • |
2009-03-09 |
4 |
B |
$0.90 |
$3,150 |
I/I |
3,500 |
4,115,265 |
1.42 |
- |
|
| Frost Gamma Investment Trust |
10% Owner |
– – • |
2009-02-11 |
4 |
B |
$0.80 |
$160 |
I/I |
200 |
4,111,765 |
1.42 |
- |
|
| Frost Gamma Investment Trust |
10% Owner |
– – • |
2009-01-30 |
4 |
B |
$0.75 |
$750 |
I/I |
1,000 |
4,111,565 |
1.42 |
- |
|
| Hsiao Jane Ph D |
Director |
– • • |
2008-05-28 |
4 |
B |
$2.15 |
$129,000 |
I/I |
60,000 |
60,000 |
2.25 |
- |
|
| Frost Gamma Investment Trust |
10% Owner |
– – • |
2008-05-27 |
4 |
B |
$2.15 |
$129,000 |
I/I |
60,000 |
4,110,565 |
1.5 |
- |
|
| Spragens Jeffrey G |
President and CEO |
• • • |
2008-05-27 |
4 |
B |
$2.15 |
$99,999 |
D/D |
46,511 |
1,734,967 |
3.23 |
- |
|
| Heithoff Kenneth |
Director |
– • – |
2008-05-27 |
4 |
B |
$2.15 |
$215,000 |
D/D |
100,000 |
100,000 |
2.39 |
- |
|
| Wayne Kevin |
Director |
– • – |
2008-05-27 |
4 |
B |
$2.15 |
$10,750 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| Frost Gamma Investment Trust |
10% Owner |
– – • |
2008-03-17 |
4 |
B |
$3.00 |
$12,857 |
I/I |
4,000 |
4,050,565 |
1.5 |
- |
|
| Frost Gamma Investment Trust |
10% Owner |
– – • |
2008-03-14 |
4 |
B |
$3.00 |
$45,000 |
I/I |
15,000 |
4,046,565 |
1.5 |
- |
|
| Frost Gamma Investment Trust |
10% Owner |
– – • |
2008-03-07 |
4 |
B |
$3.49 |
$5,245 |
I/I |
1,500 |
4,031,565 |
1.5 |
- |
|
| Frost Gamma Investment Trust |
10% Owner |
– – • |
2008-02-22 |
4 |
B |
$3.50 |
$7,000 |
I/I |
2,000 |
4,030,065 |
1.5 |
- |
|
| Katz Stephen |
Fmr. Director and Fmr. Officer |
– – – |
2007-12-20 |
4 |
S |
$3.50 |
$23,450 |
D/D |
(6,700) |
247,130 |
|
- |
|
| Spragens Jeffrey G |
President and CEO |
• • • |
2007-12-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
1,688,456 |
|
- |
|
| Frost Gamma Investment Trust |
10% Owner |
– – • |
2007-12-06 |
4 |
B |
$3.20 |
$30,455 |
I/I |
9,100 |
4,028,065 |
1.5 |
- |
|
| Spragens Jeffrey G |
President and CEO |
• • • |
2007-10-31 |
4 |
B |
$3.80 |
$1,900 |
D/D |
500 |
1,688,956 |
3.15 |
- |
|
| Frost Gamma Investment Trust |
10% Owner |
– – • |
2007-10-12 |
4 |
B |
$3.10 |
$15,745 |
I/I |
5,000 |
4,018,965 |
1.5 |
- |
|
| Spragens Jeffrey G |
President and CEOOfficer |
• • • |
2007-09-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,688,456 |
|
- |
|
| Rubin Steven D |
Director |
– • – |
2007-09-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
240,128 |
|
- |
|
| Filipi Charles |
Director |
– • • |
2007-09-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,814,092 |
|
- |
|
| Hsiao Jane Ph D |
Director |
– • • |
2007-09-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,588,965 |
2,803,965 |
|
- |
|
| Frost Gamma Investment Trust |
10% Owner |
– – • |
2007-09-04 |
4 |
A |
$0.00 |
$0 |
I/I |
2,588,965 |
4,013,965 |
|
- |
|
| Block Kenneth |
Chief Financial Officer |
• – – |
2007-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
7,500 |
|
- |
|
| Angel Joshua J |
Director |
– • – |
2007-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
28,500 |
63,750 |
|
- |
|
293 Records found
|
|
Page 11 of 12 |
|
|
